Leap Therapeutics (LPTX) shares closed a remarkable 368% higher on Nov. 12 after the company announced a crypto treasury strategy focused exclusively on ZCash (ZECUSD). According to LPTX’s press release, it secured nearly $59 million in private placement funding led by Winklevoss Capital and immediately deployed $50 million to acquire 203,775 ZEC tokens. More News from Barchart Leap will officially rebrand as Cypherpunk Technologies today, Nov. 13, and will begin trading under the new ticker symbol CYPH ...